Abstract | CONCLUSIONS: Intranasal microemulsion treatment can attenuate allergen challenge-induced nasal symptoms and plasma exudation in allergic rhinitis. We hypothesize that the mechanism of action involves modification of the allergen-mucosa interaction. The present observation suggests a novel principle for prevention in allergic rhinitis. OBJECTIVE: PATIENTS AND METHODS: Patients with allergic rhinitis were examined out of the pollen season. Treatment with a single dose of a specific microemulsion was given in a single-blind, placebo-controlled, and crossover design using a nasal pool device. Nasal allergen challenges were carried out and symptoms of allergic rhinitis were scored. Furthermore, nasal lavages were performed and levels of the plasma protein alpha 2-macroglobulin were measured as an index of exudative inflammation. RESULTS: The allergen challenges produced significant increases in nasal symptoms (p=0.007) and in nasal lavage fluid levels of alpha 2-macroglobulin (p=0.008). The challenge-induced symptoms as well as the plasma exudation were attenuated by treatment with the microemulsion (p=0.016 and 0.012, respectively, compared with placebo).
|
Authors | Morgan Andersson, Lennart Greiff, Per Wollmer |
Journal | Acta oto-laryngologica
(Acta Otolaryngol)
Vol. 128
Issue 6
Pg. 666-9
(Jun 2008)
ISSN: 0001-6489 [Print] England |
PMID | 18568502
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Allergens
- Emulsions
- alpha-Macroglobulins
|
Topics |
- Administration, Intranasal
- Adult
- Allergens
(administration & dosage, immunology)
- Desensitization, Immunologic
- Emulsions
- Female
- Humans
- Male
- Nasal Lavage Fluid
(chemistry)
- Pollen
(immunology)
- Rhinitis, Allergic, Seasonal
(immunology, therapy)
- Single-Blind Method
- alpha-Macroglobulins
(analysis)
|